MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Identification of two novel patients with VPS13D-related disease and characterization of a +3 splice site variant

    M. Pauly, N. Brüggemann, S. Efthymiou, H. Houlden, V. Chelban, F. Hinrichs, V. Tadic, A. Münchau, K. Lohmann (Lübeck, Germany)

    Objective: To identify the underlying genetic cause of a childhood-onset spasticity-ataxia-tremor syndrome in a 31-year-old woman. Background: Biallelic variants in VPS13D have been linked to…
  • 2022 International Congress

    Distribution of rapid eye movement (REM) sleep without atonia (RWA) across the REM cycles.

    A. Dagay, S. Oz, SH. Katzav, D. Wasserman, N. Giladi, A. Mirelman (Netanya, Israel)

    Objective: This study aimed to evaluate whether rapid eye movement )REM( sleep without atonia )RWA( is similar throughout multiple REM cycles during one night. Background:…
  • 2022 International Congress

    Multimodal assessment of nigrostriatal degeneration in de novo Parkinson’s disease

    M. López-Aguirre, M. Matarazzo, J. Blesa, A. Sánchez-Ferro, M. Hm Monje, J. Obeso, J. Pineda-Pardo (Móstoles, Spain)

    Objective: To study nigrostriatal changes with a multifactorial neuroimaging approach in order to further characterize early abnormalities in Parkinson’s Disease (PD). Background: Imaging techniques allow…
  • 2022 International Congress

    Social cognition and emotional processing in functional movement disorders

    A. Tomic, I. Petrovic, M. Jecmenica Lukic, N. Dragasevic Miskovic, N. Kresojevic, V. Markovic, M. Svetel, V. Kostic (Belgrade, Serbia)

    Objective: Our objective was to assess the social cognition (Theory of Mind) and emotional processing (alexithymia) in patients with functional movement disorders (FMD). Background: The…
  • 2022 International Congress

    The Correlation Analyses of Parkinson’s Disease with Serum Homocysteine, Folic Acid and Vitamin B12

    YP. Chen, Y. Qu, JT. Li, Z. Min, YJ. Xiong, Z. Xue (Wuhan, China)

    Objective: To explore the associations of serum homocysteine (Hcy), folic acid (FA) and vitamin B12 (VitB12) levels with the severity of Parkinson's disease (PD), as…
  • 2022 International Congress

    Binaural acoustic stimulation reduces tremor severity in patients suffering from Parkinson’s disease

    A. Calvano, L. Timmermann, C. Oehrn, I. Weber (Marburg, Germany)

    Objective: To assess the effects of BBS on motor symptoms in PD. Background: Acoustic stimulation (AS) can improve motor symptoms in Parkinson’s disease (PD) and…
  • 2022 International Congress

    Voluntary saccades slowness in parkinson disease and multiple system atrophy

    JY. Yoon, CY. Lee, HJ. Kim, SH. Kim (Seoul, Republic of Korea)

    Objective: This study aimed to explore and compare visually-guided and memory-guided saccades in PD and MSA. Background: Parkinson’s disease (PD) produced oculomotor alterations such as…
  • 2022 International Congress

    Aromatic L-amino acid decarboxylase deficiency: A rare disease case report and literature review

    P. Bacus, R. Sauer, T. Kini, Z. Guduru, K. Jones (Lexington, USA)

    Objective: We review the presentation of a 3-month-old patient who came to our institution with symptoms of dystonia, oculogyric crises, hypotonia, developmental delay, and dysphagia,…
  • 2022 International Congress

    Defining and restoring the underlying neural circuitry of hypersexuality in Parkinson’s Disease

    D. Mata-Marín, JA. Pineda-Pardo, M. Michiels, C. Pagge, C. Ammann, R. MARTíNEZ-FERNá[email protected], JA. Molina, L. Vela-Desojo, F. Alonso-Frech, JA. Obeso, I. Obeso (Móstoles, Spain)

    Objective: To define the neural circuitry underlying hypersexuality in Parkinson’s disease and to provide novel therapeutic options by employing neuromodulatory techniques. Background: The balance between…
  • 2022 International Congress

    Validating a virtual Timed Up and Go (vTUG) test in Parkinson’s Disease.

    C. Matthews, R. Roberts, E. Davies, B. Falkenburger, M. Grobe-Einsler (Wrexham, United Kingdom)

    Objective: To validate the vTUG as a means of remotely monitoring patient gait and balance in the home. Background: The current regulatory gold standard for…
  • « Previous Page
  • 1
  • …
  • 781
  • 782
  • 783
  • 784
  • 785
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley